Is presence of unfavorable cytogenetic abnormalities the strongest predictor of poor survival in secondary myelofibrosis?
The results of the current study suggest that cytogenetic findings might supersede AMM-derived prognostic scoring systems for predicting survival in patients with sMF.
Our studies suggest that the use of TCM cytotoxic genes is a useful therapeutic strategy for treating human cancers in general, and liver tumors in particular.